What is Zacks Research’s Forecast for PAHC Q1 Earnings?

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research lowered their Q1 2026 earnings estimates for Phibro Animal Health in a note issued to investors on Thursday, November 28th. Zacks Research analyst R. Department now forecasts that the company will earn $0.31 per share for the quarter, down from their prior estimate of $0.32. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.47 EPS, Q4 2026 earnings at $0.49 EPS and FY2026 earnings at $1.60 EPS.

PAHC has been the topic of a number of other reports. Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company. Bank of America increased their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. Finally, StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $16.50.

Phibro Animal Health Stock Down 0.9 %

Shares of Phibro Animal Health stock opened at $23.37 on Monday. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health has a 1 year low of $9.49 and a 1 year high of $25.98. The firm’s 50-day moving average is $23.32 and its two-hundred day moving average is $20.23. The stock has a market cap of $946.49 million, a price-to-earnings ratio of 54.35, a PEG ratio of 0.60 and a beta of 0.51.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC raised its position in Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after purchasing an additional 27,201 shares during the period. Barclays PLC grew its holdings in shares of Phibro Animal Health by 25.7% during the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after purchasing an additional 29,271 shares during the period. Zacks Investment Management purchased a new position in shares of Phibro Animal Health during the 3rd quarter worth $274,000. Virtus Investment Advisers Inc. grew its holdings in shares of Phibro Animal Health by 65.1% during the 3rd quarter. Virtus Investment Advisers Inc. now owns 24,344 shares of the company’s stock worth $548,000 after purchasing an additional 9,600 shares during the period. Finally, Jacobs Levy Equity Management Inc. grew its holdings in shares of Phibro Animal Health by 116.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock worth $4,330,000 after purchasing an additional 103,491 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran bought 5,000 shares of the stock in a transaction on Wednesday, September 4th. The shares were bought at an average price of $20.02 per share, with a total value of $100,100.00. Following the purchase, the director now directly owns 25,000 shares in the company, valued at $500,500. This trade represents a 25.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 50.07% of the stock is owned by corporate insiders.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.05%. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.